Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Front Behav Neurosci ; 3: 30, 2009.
Article in English | MEDLINE | ID: mdl-19826619

ABSTRACT

To investigate the role of cAMP responsive element binding protein (CREB)-dependent gene expression in morphine induced behaviors, we examined bitransgenic mice expressing a dominant and strong inhibitor of the CREB family of transcription factors, A-CREB, in striatal neurons in a regulatable manner. The expression of A-CREB in the striatum enhanced both morphine-induced conditioned place preference and morphine withdrawal-induced conditioned place avoidance. Our experiments thereby support a role for CREB in striatal neurons regulating approach and avoidance responses toward drug-related cues.

2.
Cereb Cortex ; 19(11): 2535-47, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19213815

ABSTRACT

The cAMP-responsive element-binding protein (CREB) pathway has been involved in 2 major cascades of gene expression regulating neuronal function. The first one presents CREB as a critical component of the molecular switch that controls long-lasting forms of neuronal plasticity and learning. The second one relates CREB to neuronal survival and protection. To investigate the role of CREB-dependent gene expression in neuronal plasticity and survival in vivo, we generated bitransgenic mice expressing A-CREB, an artificial peptide with strong and broad inhibitory effect on the CREB family, in forebrain neurons in a regulatable manner. The expression of A-CREB in hippocampal neurons impaired L-LTP, reduced intrinsic excitability and the susceptibility to induced seizures, and altered both basal and activity-driven gene expression. In the long-term, the chronic inhibition of CREB function caused severe loss of neurons in the CA1 subfield as well as in other brain regions. Our experiments confirmed previous findings in CREB-deficient mutants and revealed new aspects of CREB-dependent gene expression in the hippocampus supporting a dual role for CREB-dependent gene expression regulating intrinsic and synaptic plasticity and promoting neuronal survival.


Subject(s)
Brain/metabolism , CREB-Binding Protein/metabolism , Neural Inhibition , Neurodegenerative Diseases/metabolism , Neuronal Plasticity , Neurons , Synaptic Transmission , Animals , CREB-Binding Protein/antagonists & inhibitors , CREB-Binding Protein/genetics , Mice , Mice, Transgenic
3.
Learn Mem ; 16(3): 193-7, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19237641

ABSTRACT

Regulated expression of a constitutively active form of cAMP response element-binding protein (CREB), VP16-CREB, lowers the threshold for the late phase of long-term potentiation in the Schaffer collateral pathway in a de novo gene expression-independent manner, and increases the excitability and reduces afterhyperpolarization of neurons at the amygdala and the hippocampus. We explore the consequences of these changes on the consolidation of fear conditioning and find that the expression of VP16-CREB can bypass the requirement for de novo gene expression associated with long-term memory formation, suggesting that CREB-dependent gene expression is sufficient for fear memory consolidation.


Subject(s)
Amygdala/cytology , Cues , Cyclic AMP Response Element-Binding Protein/metabolism , Fear , Gene Expression Regulation/genetics , Memory/physiology , Neurons/physiology , Analysis of Variance , Animals , Anisomycin/pharmacology , Biophysical Phenomena , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Conditioning, Classical/physiology , Cyclic AMP Response Element-Binding Protein/genetics , Electric Stimulation , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Herpes Simplex Virus Protein Vmw65/genetics , Hippocampus/cytology , In Vitro Techniques , Long-Term Potentiation/drug effects , Long-Term Potentiation/genetics , Mice , Mice, Transgenic , Neurons/drug effects , Patch-Clamp Techniques/methods , Protein Synthesis Inhibitors/pharmacology
4.
J Neurosci ; 27(50): 13909-18, 2007 Dec 12.
Article in English | MEDLINE | ID: mdl-18077703

ABSTRACT

To investigate the role of CREB-mediated gene expression on the excitability of CA1 pyramidal neurons, we obtained intracellular recordings from pyramidal neurons of transgenic mice expressing a constitutively active form of CREB, VP16-CREB, in a regulated and restricted manner. We found that transgene expression increased the neuronal excitability and inhibited the slow and medium afterhyperpolarization currents. These changes may contribute to the reduced threshold for LTP observed in these mice. When strong transgene expression was turned on for prolonged period of time, these mice also showed a significant loss of hippocampal neurons and sporadic epileptic seizures. These deleterious effects were dose dependent and could be halted, but not reversed by turning off transgene expression. Our experiments reveal a new role for hippocampal CREB-mediated gene expression, identify the slow afterhyperpolarization as a primary target of CREB action, provide a new mouse model to investigate temporal lobe epilepsy and associated neurodegeneration, and illustrate the risks of cell death associated to a sustained manipulation of this pathway. As a result, our study has important implications for both the understanding of the cellular bases of learning and memory and the consideration of therapies targeted to the CREB pathway.


Subject(s)
Cyclic AMP Response Element-Binding Protein/metabolism , Epilepsy, Temporal Lobe/physiopathology , Gene Expression Regulation , Hippocampus/physiopathology , Neurodegenerative Diseases/physiopathology , Pyramidal Cells/physiopathology , Animals , Cyclic AMP Response Element-Binding Protein/genetics , Disease Models, Animal , Electric Stimulation , Epilepsy, Temporal Lobe/genetics , Female , Handling, Psychological , Hippocampus/pathology , Long-Term Potentiation/genetics , Male , Mice , Mice, Transgenic , Neurodegenerative Diseases/genetics , Organ Culture Techniques , Patch-Clamp Techniques , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Survival Rate , Synaptic Transmission/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...